| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 15.024 | 12.307 | 10.733 | 10.988 | 10.853 | 1.687 | 101 | 0 | 0 | 0 |
| Total Income - EUR | 15.024 | 12.307 | 10.733 | 10.988 | 10.853 | 1.722 | 177 | 158 | 276 | 63 |
| Total Expenses - EUR | 10.653 | 8.521 | 7.642 | 7.101 | 5.757 | 1.459 | 110 | 101 | 72 | 78 |
| Gross Profit/Loss - EUR | 4.371 | 3.787 | 3.091 | 3.887 | 5.095 | 263 | 67 | 57 | 204 | -15 |
| Net Profit/Loss - EUR | 3.920 | 3.452 | 2.769 | 3.563 | 4.757 | 209 | 64 | 52 | 171 | -21 |
| Employees | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Folimed S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 956 | 148 | 1.248 | 1.072 | 901 | 847 | 828 | 831 | 828 | 823 |
| Current Assets | 4.789 | 4.519 | 3.868 | 4.795 | 8.309 | 8.021 | 7.678 | 6.724 | 6.878 | 1.987 |
| Inventories | 1.396 | 1.381 | 1.437 | 1.602 | 1.571 | 1.541 | 1.507 | 1.512 | 1.507 | 1.499 |
| Receivables | 164 | 163 | 160 | 157 | 154 | 144 | 148 | 141 | 133 | 133 |
| Cash | 3.229 | 2.975 | 2.271 | 3.036 | 6.585 | 6.335 | 6.023 | 5.071 | 5.238 | 356 |
| Shareholders Funds | 4.720 | 4.243 | 3.547 | 4.327 | 5.506 | 944 | 782 | 766 | 883 | 687 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 1.025 | 424 | 1.569 | 1.540 | 3.704 | 7.924 | 7.724 | 6.788 | 6.823 | 2.124 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8623 - 8623" | |||||||||
| CAEN Financial Year |
8623
|
|||||||||
Comments - Folimed S.r.l.